Dr. Reddy's Laboratories — Fact Sheet (August 2012)

2 slides from Dr. Reddy's Laboratories's fact sheet, August 2012

Slide 1: Key Company updates
Key Company updates: * Launched Over-the-Counter fexofenadine HC! tablets ‘+ Expanded its R&D centre in Cambridge, United Kingdom * Promius™ Pharma and Valeant formed collaboration to market Cloderm* cream in the United states * Launched pegfilgrastim in India under the brand name 'Peg-grafeel ™ Rec
Slide 2: Financial Results: Q1 FY12
Financial Results: Q1 FY12 + Revenue: £1,978 crs + Adjusted EBIDTA* : 434 crs + Adjustet PAT** 252 crs * Globally 39 new product launches & 31 product filings * Includes a one-time charge of €14 Cr on account of a Voluntary Retirement Scheme (VRS) floated by the company “*Tincludes: a) interest on b